EirGen Pharma
About Us
Company Overview
Our Approach
Our Team
Approvals
Global Operations
Quality
About OPKO
Community
R&D
Capabilities
How we do things
Partner with EirGen R&D
Commercial
Capabilities
How We Do Things
Partner with EirGen
News
Join Us
Work with Us
Job Opportunities
World Class Location
Contact Us
COMMERCIAL
Show All
COMMERCIAL
COMMUNITY
COMPANY UPDATES
News
R&D
All
COMMERCIAL
COMMUNITY
COMPANY UPDATES
News
R&D
EirGen Pharma Product Eir-102 Passes Bioequivalence Study in US
April 17, 2017
Read More
FDA Approval for EirGen Product EIR-087
March 23, 2017
Read More
EirGen Pharma successfully completes Pre-Approval Inspection with US FDA
March 3, 2017
Read More
OPKO Announces U.S. Launch of RAYALDEE™
November 23, 2016
Read More
EirGen Pharma Product EIR-050 Launches in Mexico
March 31, 2016
Read More
EirGen Pharma Product Eir-126 Passes Bioequivalence Study in US
February 29, 2016
Read More
EirGen Pharma Product EIR-116 receives first Regulatory Approval
February 26, 2016
Read More
ANDA Approval for EirGen Product EIR-060
February 11, 2016
Read More
EirGen Pharma Product EIR-101 Passes Bioequivalence Study
September 30, 2015
Read More
Posts navigation
Older Entries
